Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607738028407) titled 'Therapeutic Efficacy Study' on July 31.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Permuted block randomization,Allocation was determined by the holder of the sequence who is situated off site
Primary Sponsor: PATH
Condition:
Malaria
Malaria
Intervention:
Artemether Lumefantrine
Recruitment Status: Not Recruiting
Phase: Not Applicable
Date of First Enrollment: 01/12/2026
Target Sample Size: 500
Countries of Recruitment:
Kenya
To know more, visit https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=4378...